Compare NVAX & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVAX | EE |
|---|---|---|
| Founded | 1987 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1996 | 2022 |
| Metric | NVAX | EE |
|---|---|---|
| Price | $10.00 | $36.64 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $11.33 | ★ $39.20 |
| AVG Volume (30 Days) | ★ 5.3M | 357.0K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | ★ 309.76 | 0.79 |
| EPS | N/A | ★ 0.75 |
| Revenue | $1,123,479,000.00 | ★ $1,228,263,000.00 |
| Revenue This Year | N/A | $23.59 |
| Revenue Next Year | N/A | $24.37 |
| P/E Ratio | ★ N/A | $47.81 |
| Revenue Growth | ★ 64.69 | 44.26 |
| 52 Week Low | $6.20 | $23.55 |
| 52 Week High | $11.85 | $43.18 |
| Indicator | NVAX | EE |
|---|---|---|
| Relative Strength Index (RSI) | 52.31 | 34.94 |
| Support Level | $9.14 | $35.00 |
| Resistance Level | $10.10 | $36.04 |
| Average True Range (ATR) | 0.58 | 1.48 |
| MACD | -0.08 | -0.44 |
| Stochastic Oscillator | 23.66 | 4.09 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.